Couverture de EconRx

EconRx

EconRx

De : Aaron Young
Écouter gratuitement

À propos de cette écoute

 In this show we dive into the business of the US healthcare system. Why are some of my medications covered by insurance but not others? What does it mean for a provider to be "in-network?" Above all, WHERE DO OUR HEALTHCARE DOLLARS GO??! We want to understand and answer these questions, and we want you to come with us on this journey. Economie Hygiène et vie saine Maladie et pathologies physiques
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • Alzheimer's Boom or Bust

      Alzheimer's Boom or Bust
      Oct 14 2022

      Aducanumab (brand name Aduhelm) drew headlines when it was approved by the FDA in 2021 against the recommendations of the FDA advisory committee. Today it's almost commercially dead. On this episode are joined by P4 student Ise Brockmann to dive into aducanumab's story.

      email: econrxpodcast@gmail.com

      Twitter/Instagram: @EconRx

      LinkedIn: www.linkedin.com/company/econrx

      Website: https://econrx.libsyn.com/
      Afficher plus Afficher moins
      1 h et 5 min
    • $35 Insulin Cap

      $35 Insulin Cap
      Apr 21 2022

      Capping patient out-of-pocket costs for insulin has been a popular move for legislators, most recently by the US House. On this episode we weigh the Pros, Cons, and viral reactions to this move including lowering vs. shifting costs, ADA guidelines, and political theater.

      email: econrxpodcast@gmail.com

      Twitter/Instagram: @EconRx

      LinkedIn: www.linkedin.com/company/econrx

      Website: https://econrx.libsyn.com/
      Afficher plus Afficher moins
      43 min
    • Testing Woes & Ivermectin

      Testing Woes & Ivermectin
      Sep 27 2021

      After explaining a HORRENDOUS mistake made recently by the NABP and the oversight of NAPLEX testing that affected one of our own, we decided it's high time we dove into the controversy around the use of ivermectin against COVID-19. Social media and mainstream news can be confusing, so we tried to summarize while sticking to what is known. If we missed something, please let us know!

      email: econrxpodcast@gmail.com

      Twitter/Instagram: @EconRx

      LinkedIn: www.linkedin.com/company/econrx

      Website: https://econrx.libsyn.com/
      Afficher plus Afficher moins
      53 min

    Ce que les auditeurs disent de EconRx

    Moyenne des évaluations utilisateurs. Seuls les utilisateurs ayant écouté le titre peuvent laisser une évaluation.

    Commentaires - Veuillez sélectionner les onglets ci-dessous pour changer la provenance des commentaires.

    Commentaires Audible.fr

    Commentaires Amazon
    Il n'y a pas encore de critique disponible pour ce titre.